Holding(s) in Company
September 16 2010 - 3:29AM
UK Regulatory
TIDMGWP
RNS Number : 7995S
GW Pharmaceuticals PLC
16 September 2010
+------------+---------------------+---------------------+---------------------+-----+
| |
+------------------------------------------------------------------------------------+
| TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi |
+------------------------------------------------------------------------------------+
| | |
+--------------------------------------------------------+---------------------------+
| 1. Identity of the issuer or the underlying issuer | GW Pharmaceuticals |
| of existing shares to which voting rights are | |
| attached: ii | |
+--------------------------------------------------------+---------------------------+
| 2 Reason for the notification (please tick the appropriate box or boxes): |
+------------------------------------------------------------------------------------+
| An acquisition or disposal of voting rights | X |
+------------------------------------------------------------------------------+-----+
| An acquisition or disposal of qualifying financial instruments which may | |
| result in the acquisition of shares already issued to which voting rights | |
| are attached | |
+------------------------------------------------------------------------------+-----+
| An acquisition or disposal of instruments with similar economic effect to | |
| qualifying financial instruments | |
+------------------------------------------------------------------------------+-----+
| An event changing the breakdown of voting rights | |
+------------------------------------------------------------------------------+-----+
| Other | | |
| (please | | |
| specify): | | |
+------------+-----------------------------------------------------------------+-----+
| 3. Full name of person(s) | |
| subject to the | M&G Investment Funds 3 |
| notification obligation: iii | |
+----------------------------------+-------------------------------------------------+
| 4. Full name of shareholder(s) | |
| (if different from 3.):iv | |
| | Nortrust Nominee Ltd A/C MKK01 |
| | |
| | |
+----------------------------------+-------------------------------------------------+
| 5. Date of the transaction and | 14 September 2010 |
| date on | |
| which the threshold is crossed | |
| or | |
| reached: v | |
+----------------------------------+-------------------------------------------------+
| 6. Date on which issuer | 15 September 2010 |
| notified: | |
+----------------------------------+-------------------------------------------------+
| 7. Threshold(s) that is/are | 10%-11% |
| crossed or | |
| reached: vi, vii | |
+----------------------------------+-------------------------------------------------+
| | | | | |
+------------+---------------------+---------------------+---------------------+-----+
+--------------+----------+----+------+-------+----+----+----------+----+-------+----+----------+-----+---------+----+-----+-------+
| 8. Notified details: |
+----------------------------------------------------------------------------------------------------------------------------------+
| A: Voting rights attached to shares viii, ix |
+----------------------------------------------------------------------------------------------------------------------------------+
| Class/type | Situation previous | Resulting situation after the triggering |
| of | to the triggering | transaction |
| shares | transaction | |
| if | | |
| possible | | |
| using | | |
| the ISIN | | |
| CODE | | |
+ +----------------------------------------+--------------------------------------------------------------------------+
| | Number | Number | Number | Number of | % of voting rights x |
| | of | of | of | voting | |
| | Shares | Voting | shares | rights | |
| | | Rights | | | |
+ + + +---------------+-----------------------+----------------------------------+
| | | | Direct | Direct | Indirect | Direct | Indirect |
| | | | | xi | xii | | |
+--------------+----------------------+-----------------+---------------+------------+----------+--------------------+-------------+
|GB0030544687 | 14,005,611 | 14,005,611 | 14,310,611 |14,310,611 | 0 | 11.02% | |
+--------------+----------------------+-----------------+---------------+------------+----------+--------------------+-------------+
| | | | | | | | |
+--------------+----------------------+-----------------+---------------+------------+----------+--------------------+-------------+
| |
+----------------------------------------------------------------------------------------------------------------------------------+
| B: Qualifying Financial Instruments |
+----------------------------------------------------------------------------------------------------------------------------------+
| Resulting situation after the triggering transaction |
+----------------------------------------------------------------------------------------------------------------------------------+
| Type of financial | Expiration | Exercise/ | Number of voting | % of voting |
| instrument | date xiii | Conversion Period xiv | rights that may be | rights |
| | | | acquired if the | |
| | | | instrument is | |
| | | | exercised/ | |
| | | | converted. | |
+------------------------------+--------------+---------------------------------+-------------------------------+------------------+
| | | | | |
+------------------------------+--------------+---------------------------------+-------------------------------+------------------+
| |
+----------------------------------------------------------------------------------------------------------------------------------+
| C: Financial Instruments with similar economic effect to Qualifying Financial Instruments |
| xv, xvi |
+----------------------------------------------------------------------------------------------------------------------------------+
| Resulting situation after the triggering transaction |
+----------------------------------------------------------------------------------------------------------------------------------+
| Type of | Exercise | Expiration | Exercise/ | Number of voting | % of voting |
| financial | price | date xvii | Conversion | rights instrument | rights xix, xx |
| instrument | | | period xviii | refers to | |
| | | | | | |
+-------------------------+-----------+------------+--------------------+-----------------------------+----------------------------+
| | | | | | Nominal | Delta |
| | | | | | | |
+ + + + + +--------------------+-------+
| | | | | | | |
+-------------------------+-----------+------------+--------------------+-----------------------------+--------------------+-------+
| |
+----------------------------------------------------------------------------------------------------------------------------------+
| Total (A+B+C) |
+----------------------------------------------------------------------------------------------------------------------------------+
| Number of voting rights | Percentage of voting rights |
+------------------------------------------------------------------+---------------------------------------------------------------+
| 14,310,611 | 11.02% |
+------------------------------------------------------------------+---------------------------------------------------------------+
| | | | | | | | | | | | | | | | | |
+--------------+----------+----+------+-------+----+----+----------+----+-------+----+----------+-----+---------+----+-----+-------+
+----------------------------+-------------------------------+---------------------+
| 9. Chain of controlled undertakings through which the voting rights and/or the |
| financial instruments are effectively held, if applicable: xxi |
+----------------------------------------------------------------------------------+
| |
+----------------------------------------------------------------------------------+
| |
+----------------------------------------------------------------------------------+
| Proxy Voting: |
+----------------------------------------------------------------------------------+
| 10. Name of the proxy holder: | N/A |
+------------------------------------------------------------+---------------------+
| 11. Number of voting rights proxy holder will cease | N/A |
| to hold: | |
+------------------------------------------------------------+---------------------+
| 12. Date on which proxy holder will cease to hold | N/A |
| voting rights: | |
+------------------------------------------------------------+---------------------+
| |
+----------------------------------------------------------------------------------+
| 13. Additional | With reference to item 3, M&G Investments Funds 3 |
| information: | is an Open Ended Investment Company (OEIC) and is |
| | not a Prudential group company and must be |
| | separately disclosed. |
| | This OEIC Fund is managed by M&G Investment |
| | Management Limited (a wholly owned subsidiary of |
| | Prudential plc) and will have been previously |
| | attributed to Prudential plc solely on the basis |
| | that M&G Investment Management Ltd has direct fund |
| | management control over the shares identified in |
| | this notification. |
| | |
| | Therefore the 11.02% holding being disclosed in |
| | this notification is encompassed in the 12.18% |
| | already disclosed under The Prudential plc group of |
| | companies and is NOT in addition to it. |
| | |
+----------------------------+-----------------------------------------------------+
| 14. Contact name: | Ryan Dowling / Mark Thomas |
| | M&G Investment Management Limited |
+----------------------------+-----------------------------------------------------+
| 15. Contact telephone | 020 7548 2979 / 020 7548 3266 |
| number: | |
+----------------------------+-----------------------------------------------------+
| | | |
+----------------------------+-------------------------------+---------------------+
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLEAPNKFAXEEEF
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about GW Pharm. (London Stock Exchange): 0 recent articles
More Gw Pharmaceuticals News Articles